Illumina, Inc. (ILMN) Shares Bought by National Pension Service

National Pension Service boosted its holdings in shares of Illumina, Inc. (NASDAQ:ILMN) by 1.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 137,418 shares of the life sciences company’s stock after buying an additional 1,693 shares during the period. National Pension Service owned approximately 0.09% of Illumina worth $30,024,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Intellectus Partners LLC boosted its stake in Illumina by 6.6% during the second quarter. Intellectus Partners LLC now owns 10,783 shares of the life sciences company’s stock valued at $1,871,000 after buying an additional 664 shares during the period. Axiom International Investors LLC DE boosted its stake in Illumina by 60.9% during the third quarter. Axiom International Investors LLC DE now owns 186,457 shares of the life sciences company’s stock valued at $37,142,000 after buying an additional 70,572 shares during the period. Virtu Financial LLC bought a new stake in Illumina during the third quarter valued at $577,000. Janus Henderson Group PLC boosted its stake in Illumina by 1,556.2% during the second quarter. Janus Henderson Group PLC now owns 330,010 shares of the life sciences company’s stock valued at $57,263,000 after buying an additional 310,084 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its stake in Illumina by 4.9% during the third quarter. Schwab Charles Investment Management Inc. now owns 508,368 shares of the life sciences company’s stock valued at $101,267,000 after buying an additional 23,647 shares during the period. 91.60% of the stock is owned by institutional investors.

In other news, SVP Charles Dadswell sold 1,609 shares of Illumina stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $207.88, for a total value of $334,478.92. Following the transaction, the senior vice president now owns 7,217 shares in the company, valued at $1,500,269.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Jay T. Flatley sold 20,000 shares of Illumina stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $210.43, for a total value of $4,208,600.00. Following the completion of the transaction, the director now owns 539,176 shares in the company, valued at approximately $113,458,805.68. The disclosure for this sale can be found here. In the last quarter, insiders sold 154,671 shares of company stock worth $33,626,228. Company insiders own 0.89% of the company’s stock.

ILMN has been the subject of several research analyst reports. Citigroup lifted their price objective on Illumina from $180.00 to $220.00 and gave the company a “neutral” rating in a research note on Wednesday, October 25th. Robert W. Baird raised Illumina from a “neutral” rating to an “outperform” rating and lifted their price objective for the company from $184.00 to $228.00 in a research note on Wednesday, October 25th. Zacks Investment Research lowered Illumina from a “buy” rating to a “hold” rating in a research note on Tuesday, December 26th. Barclays lifted their price objective on Illumina from $150.00 to $185.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 25th. Finally, BidaskClub lowered Illumina from a “buy” rating to a “hold” rating in a research note on Wednesday, December 6th. One analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have given a buy rating to the company. Illumina presently has a consensus rating of “Buy” and a consensus target price of $220.13.

Shares of Illumina, Inc. (ILMN) opened at $241.31 on Friday. Illumina, Inc. has a 12-month low of $156.50 and a 12-month high of $248.97. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.73 and a current ratio of 4.22. The firm has a market capitalization of $35,230.00, a PE ratio of 45.53, a price-to-earnings-growth ratio of 3.25 and a beta of 0.79.

Illumina (NASDAQ:ILMN) last released its quarterly earnings results on Tuesday, October 24th. The life sciences company reported $1.11 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.99 by $0.12. The business had revenue of $714.00 million for the quarter, compared to the consensus estimate of $692.77 million. Illumina had a return on equity of 19.42% and a net margin of 30.34%. The company’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter last year, the business posted $0.97 earnings per share. equities research analysts forecast that Illumina, Inc. will post 3.76 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Illumina, Inc. (ILMN) Shares Bought by National Pension Service” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://stocknewstimes.com/2018/01/19/illumina-inc-ilmn-shares-bought-by-national-pension-service.html.

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply